Susquehanna International Group, LLP Regeneron Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

  • $823 Billion
  • Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 190,176 shares of REGN stock, worth $132 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
190,176
Previous 164,092 15.9%
Holding current value
$132 Million
Previous $86.1 Million 24.12%
% of portfolio
0.01%
Previous 0.01%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$534.91 - $598.71 $14 Million - $15.6 Million
26,084 Added 15.9%
190,176 $107 Million
Q2 2025

Aug 14, 2025
BUY
$483.07 - $625.6 $6.1 Million - $7.9 Million
12,634 Added 8.34%
164,092 $86.1 Million
Q1 2025

May 14, 2025
BUY
$634.14 - $744.83 $43.9 Million - $51.6 Million
69,266 Added 84.27%
151,458 $96.1 Million
Q4 2024

Feb 14, 2025
BUY
$701.85 - $1046.91 $34.2 Million - $51 Million
48,682 Added 145.28%
82,192 $58.5 Million
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $3.17 Million - $3.72 Million
3,098 Added 10.19%
33,510 $35.2 Million
Q2 2024

Aug 15, 2024
SELL
$883.2 - $1071.19 $5.79 Million - $7.03 Million
-6,561 Reduced 17.75%
30,412 $32 Million
Q1 2024

May 07, 2024
SELL
$902.69 - $993.35 $48 Million - $52.9 Million
-53,224 Reduced 59.01%
36,973 $35.6 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $27.4 Million - $31.2 Million
35,337 Added 64.41%
90,197 $79.2 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $13.3 Million - $16.2 Million
-19,157 Reduced 25.88%
54,860 $45.1 Million
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $15.5 Million - $18.4 Million
-22,187 Reduced 23.06%
74,017 $53.2 Million
Q1 2023

May 16, 2023
BUY
$680.49 - $826.97 $10.7 Million - $13 Million
15,707 Added 19.51%
96,204 $79 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $40.5 Million - $44 Million
57,355 Added 247.84%
80,497 $58.1 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $14.7 Million - $18.5 Million
-25,609 Reduced 52.53%
23,142 $15.9 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $6.89 Million - $9.28 Million
-12,561 Reduced 20.49%
48,751 $28.8 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $68.3 Million - $80.1 Million
-114,711 Reduced 65.17%
61,312 $42.8 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $51.2 Million - $63.2 Million
-94,140 Reduced 34.85%
176,023 $111 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $50.6 Million - $60 Million
-88,164 Reduced 24.6%
270,163 $163 Million
Q2 2021

Aug 11, 2021
BUY
$472.8 - $558.54 $68.2 Million - $80.5 Million
144,175 Added 67.32%
358,327 $200 Million
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $223 Million - $273 Million
-498,689 Reduced 69.96%
214,152 $101 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $248 Million - $315 Million
518,331 Added 266.48%
712,841 $344 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $49.1 Million - $59.4 Million
90,210 Added 86.49%
194,510 $109 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $34.1 Million - $44.5 Million
69,067 Added 196.03%
104,300 $65 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $9.66 Million - $14.2 Million
-28,736 Reduced 44.92%
35,233 $17.2 Million
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $54.4 Million - $74.7 Million
-198,283 Reduced 75.61%
63,969 $24 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $20.7 Million - $24.1 Million
75,791 Added 40.65%
262,252 $72.7 Million
Q2 2019

Aug 16, 2019
BUY
$299.6 - $414.82 $17.8 Million - $24.7 Million
59,560 Added 46.93%
186,461 $58.4 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $37 Million - $51.3 Million
123,590 Added 3732.71%
126,901 $39.7 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $914,944 - $1.08 Million
2,459 Added 288.62%
3,311 $1.36 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $1.51 Million - $1.82 Million
-4,505 Reduced 84.1%
852 $318,000
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $57.7 Million - $67.1 Million
-164,234 Reduced 96.84%
5,357 $2.16 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $39.2 Million - $47.5 Million
137,780 Added 433.12%
169,591 $58.5 Million
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $5.23 Million - $6.52 Million
16,564 Added 108.64%
31,811 $11 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $4.11 Million - $5.38 Million
11,447 Added 301.24%
15,247 $5.73 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $1.64 Million - $1.92 Million
3,800
3,800 $1.7 Million

Others Institutions Holding REGN

# of Institutions
1,521
Shares Held
86.5M
Call Options Held
2.38M
Put Options Held
1.61M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email